The challenge of targeting cancer stem cells to halt metastasis.

[1]  Patrick Soon-Shiong,et al.  Molecular heterogeneity in breast cancer: State of the science and implications for patient care. , 2017, Seminars in cell & developmental biology.

[2]  Y. Einaga,et al.  Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205) , 2017, Gastric Cancer.

[3]  M. Griswold,et al.  Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients , 2017, Translational oncology.

[4]  W. Walters,et al.  Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species , 2017, BMC Cancer.

[5]  Dhiraj Kumar,et al.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma , 2017, Molecular Cancer.

[6]  T. Bekaii-Saab,et al.  Identifying and targeting cancer stem cells in the treatment of gastric cancer , 2017, Cancer.

[7]  R. Khokha,et al.  MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 , 2017, Oncogene.

[8]  K. Chan,et al.  Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma , 2016, Nature Communications.

[9]  Alexey P. Porfirev,et al.  Polarization conversion when focusing cylindrically polarized vortex beams , 2016, Scientific Reports.

[10]  Wei Zhao,et al.  Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells , 2016, Front. Pharmacol..

[11]  Deric M. Park,et al.  Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma , 2016, Journal of Neuro-Oncology.

[12]  W. Fan,et al.  Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics , 2016, Molecular medicine reports.

[13]  S. Gollin,et al.  Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. , 2016, Experimental cell research.

[14]  Xiaoyuan Song,et al.  Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin , 2016, Scientific Reports.

[15]  K. Okkenhaug,et al.  Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. , 2016, Cancer discovery.

[16]  Steven J. Greco,et al.  Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow. , 2016, Cancer research.

[17]  Jie Gao,et al.  Codelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cells. , 2016, Nanomedicine.

[18]  Koji Okamoto,et al.  TNIK inhibition abrogates colorectal cancer stemness , 2016, Nature Communications.

[19]  E. Hurt,et al.  Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. , 2016, Cancer research.

[20]  X. Shao,et al.  NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling , 2016, Oncotarget.

[21]  S. Gurunathan,et al.  Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy , 2016, International journal of nanomedicine.

[22]  G. Semenza,et al.  PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis. , 2016, Cancer research.

[23]  A. Brandes,et al.  A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. , 2016, Neuro-oncology.

[24]  Su In Lee,et al.  Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer , 2016, Oncotarget.

[25]  S. Dong,et al.  An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors. , 2016, Biomaterials.

[26]  G. Kibria,et al.  miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway , 2016, Clinical Cancer Research.

[27]  M. Mi,et al.  3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway , 2016, Scientific Reports.

[28]  S. Takao,et al.  Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition , 2016, Molecular Cancer.

[29]  Jacques Haiech,et al.  Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy , 2016, Stem cells international.

[30]  E. Rofstad,et al.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies , 2016, Oncotarget.

[31]  Xiaolong Wang,et al.  Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells , 2016, Cell & Bioscience.

[32]  J. Dick,et al.  miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia. , 2016, Cancer cell.

[33]  J. Guan,et al.  Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling. , 2016, Cancer research.

[34]  Guoping Zhao,et al.  CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs. , 2016, Oncology reports.

[35]  L. Hood,et al.  TGFβ‐Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme , 2016, Stem cells.

[36]  F. Sotgia,et al.  Cancer stem cell metabolism , 2016, Breast Cancer Research.

[37]  W. Edenfield,et al.  A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer. , 2016 .

[38]  F. Marcucci,et al.  Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal , 2016, Front. Oncol..

[39]  F. Verhaegen,et al.  NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma , 2016, Oncotarget.

[40]  K. Peck,et al.  Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial , 2016, Clinical Cancer Research.

[41]  S. Do,et al.  Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma , 2016, Laboratory Investigation.

[42]  J. Meléndez-Zajgla,et al.  miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation , 2016, EMBO reports.

[43]  F. Sotgia,et al.  Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells , 2016, Oncotarget.

[44]  R. Majeti,et al.  SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells , 2016, Clinical Cancer Research.

[45]  P. Theodoropoulos,et al.  Stem cell technology in breast cancer: current status and potential applications , 2016, Stem cells and cloning : advances and applications.

[46]  A. Kulkarni,et al.  NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell , 2016, Scientific Reports.

[47]  X. Yang,et al.  Gastric Lgr5+ stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice , 2016, Cell Research.

[48]  Xin Chen,et al.  Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer , 2016, Clinical Cancer Research.

[49]  A. Carnero,et al.  The hypoxic microenvironment: A determinant of cancer stem cell evolution , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[50]  Aaron M. Newman,et al.  Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors , 2016, Proceedings of the National Academy of Sciences.

[51]  K. O'Byrne,et al.  Lung cancer stem cells: The root of resistance. , 2016, Cancer letters.

[52]  Elisa de Stanchina,et al.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.

[53]  E. Garrido,et al.  Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression , 2016, Oncotarget.

[54]  B. Das,et al.  Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1 , 2016, Clinical Cancer Research.

[55]  D. Salomon,et al.  Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer , 2016, Breast Cancer Research and Treatment.

[56]  Jeong-Seok Nam,et al.  CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment , 2016, Oncotarget.

[57]  G. Semenza,et al.  The hypoxic tumor microenvironment: A driving force for breast cancer progression. , 2016, Biochimica et biophysica acta.

[58]  N. Mitsutake,et al.  Cancer Stem Cells in the Thyroid , 2016, Front. Endocrinol..

[59]  Steven H. Lin,et al.  PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness , 2016, Nature Communications.

[60]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[61]  J. Grandis,et al.  Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population. , 2016, Cancer research.

[62]  A. Sette,et al.  Cripto-1 vaccination elicits protective immunity against metastatic melanoma , 2016, Oncoimmunology.

[63]  M. Jackson,et al.  Cancer Stem Cell Plasticity Drives Therapeutic Resistance , 2016, Cancers.

[64]  Rajashri R. Parab,et al.  Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells , 2015, Oncotarget.

[65]  P. Carmeliet,et al.  FOXO1 couples metabolic activity and growth state in the vascular endothelium , 2015, Nature.

[66]  M. Khazaei,et al.  New Findings on Breast Cancer Stem Cells: A Review , 2015, Journal of breast cancer.

[67]  I. Spiteri,et al.  Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence , 2015, Front. Oncol..

[68]  H. Utsumi,et al.  Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors , 2015, Cancer Chemotherapy and Pharmacology.

[69]  R. Salgia,et al.  Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  F. E. Bertrand,et al.  Notch‐1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer , 2015, Journal of cellular biochemistry.

[71]  Yanning Liu,et al.  Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma , 2015, Journal of Hematology & Oncology.

[72]  Jie J. Zheng,et al.  Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled* , 2015, The Journal of Biological Chemistry.

[73]  A. Giordano,et al.  Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling , 2015, Oncotarget.

[74]  Xin-hua Liang,et al.  Links between cancer stem cells and epithelial–mesenchymal transition , 2015, OncoTargets and therapy.

[75]  Jeong-Seok Nam,et al.  Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells , 2015, Oncotarget.

[76]  S. Shankar,et al.  PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth , 2015, Oncotarget.

[77]  W. Liang,et al.  Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. , 2015, International journal of clinical and experimental pathology.

[78]  K. Bae,et al.  FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. , 2015, Gastroenterology.

[79]  M. Garg.  Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy. , 2015, World journal of stem cells.

[80]  Chih-Yang Wang,et al.  Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.

[81]  I. Weissman,et al.  Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential , 2015, PloS one.

[82]  A. Ben-Ze'ev,et al.  Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis , 2015, Oncotarget.

[83]  M. Donadelli,et al.  The metabolic landscape of cancer stem cells , 2015, IUBMB life.

[84]  R. Fodde,et al.  IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden. , 2015, Cancer research.

[85]  Paul Workman,et al.  Drugging PI3K in cancer: refining targets and therapeutic strategies , 2015, Current opinion in pharmacology.

[86]  Michael Kahn,et al.  Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update , 2015, Nature Reviews Clinical Oncology.

[87]  A. Abrantes,et al.  Clinical translation for endometrial cancer stem cells hypothesis , 2015, Cancer and Metastasis Reviews.

[88]  S. Scala.  Molecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment , 2015, Clinical Cancer Research.

[89]  D. Scadden,et al.  Notch Receptor‐Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche Retention , 2015, Stem cells.

[90]  M. Shah,et al.  The BRIGHTER trial: A phase III randomized double-blind study of BBI608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma. , 2015 .

[91]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[92]  E. Turlizzi,et al.  Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway. , 2015, European journal of medicinal chemistry.

[93]  E. Morii,et al.  Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. , 2015, Gynecologic oncology.

[94]  D. Stolz,et al.  Identification of a candidate stem cell in human gallbladder. , 2015, Stem cell research.

[95]  H. Mackay,et al.  A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. , 2015, Gynecologic oncology.

[96]  S. Digumarthy,et al.  Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor. , 2015, Cancer discovery.

[97]  Jeong-Seok Nam,et al.  Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells. , 2015, Cancer research.

[98]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[99]  Z. Werb,et al.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.

[100]  T. Carey,et al.  Cancer stem cells: Mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma , 2015, Head & neck.

[101]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[102]  J. Phillips,et al.  Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells , 2015, PloS one.

[103]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[104]  F. Rohdich,et al.  Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen , 2015, Journal of medicinal chemistry.

[105]  M. Wicha,et al.  Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity , 2015, Molecular Cancer Therapeutics.

[106]  A. Jimeno,et al.  Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. , 2015, Pharmacology & therapeutics.

[107]  I. López,et al.  The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties. , 2015, Cancer letters.

[108]  E. Hurt,et al.  Cancer stem cell plasticity and tumor hierarchy. , 2015, World journal of stem cells.

[109]  H. A. Rogoff,et al.  Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.

[110]  Qunli Xu,et al.  PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. , 2015, Cancer research.

[111]  Mirko H. H. Schmidt,et al.  Notching on Cancer’s Door: Notch Signaling in Brain Tumors , 2015, Front. Oncol..

[112]  C. Watts,et al.  Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase , 2015, Molecular oncology.

[113]  L. Ellis,et al.  The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells , 2014, British Journal of Cancer.

[114]  J. Baselga,et al.  Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer , 2014, Investigational New Drugs.

[115]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[116]  V. Zellmer,et al.  Evolving concepts of tumor heterogeneity , 2014, Cell & Bioscience.

[117]  J. Baselga,et al.  First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma , 2014, Clinical Cancer Research.

[118]  Leonid Peshkin,et al.  A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis , 2014, Cell.

[119]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[120]  You-hong Cui,et al.  Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells. , 2014, Cancer research.

[121]  S. Hilsenbeck,et al.  STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer , 2014, Stem cells.

[122]  Edward J. Kim,et al.  Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma , 2014, Clinical Cancer Research.

[123]  Jingting Jiang,et al.  Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival. , 2014, International journal of clinical and experimental pathology.

[124]  M. Kahn,et al.  Safely targeting cancer stem cells via selective catenin coactivator antagonism , 2014, Cancer science.

[125]  C. Swanton,et al.  Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine , 2014, Genome Biology.

[126]  M. Simon,et al.  Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. , 2014, Trends in cell biology.

[127]  J. Wischhusen,et al.  Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape? , 2014, Front. Immunol..

[128]  R. Weinberg,et al.  Tackling the cancer stem cells — what challenges do they pose? , 2014, Nature Reviews Drug Discovery.

[129]  M. Mollenhauer,et al.  Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine , 2014, Oncotarget.

[130]  Miao Sun,et al.  Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression , 2014, Medical Oncology.

[131]  Ping Li,et al.  A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway , 2014, Oncotarget.

[132]  A. Calvo,et al.  Metastatic dormancy: a complex network between cancer stem cells and their microenvironment. , 2014, Histology and histopathology.

[133]  Denis Wirtz,et al.  Hypoxia and the extracellular matrix: drivers of tumour metastasis , 2014, Nature Reviews Cancer.

[134]  Emma R. Andersson,et al.  Therapeutic modulation of Notch signalling — are we there yet? , 2014, Nature Reviews Drug Discovery.

[135]  E. Batlle,et al.  TGF-beta in CAF-mediated tumor growth and metastasis. , 2014, Seminars in cancer biology.

[136]  Keisuke Ito,et al.  Metabolic requirements for the maintenance of self-renewing stem cells , 2014, Nature Reviews Molecular Cell Biology.

[137]  A. Dubrovska,et al.  CXCR4 as biomarker for radioresistant cancer stem cells , 2014, International journal of radiation biology.

[138]  T. Oskarsson,et al.  Metastatic stem cells: sources, niches, and vital pathways. , 2014, Cell stem cell.

[139]  C. Rommel,et al.  PI3K and cancer: lessons, challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[140]  F. Kopp,et al.  Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration , 2014, Molecular Cancer.

[141]  Sagi Abelson,et al.  Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations , 2013, PloS one.

[142]  J. Panyam,et al.  CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[143]  S. Okazaki,et al.  Redox regulation in stem-like cancer cells by CD44 variant isoforms , 2013, Oncogene.

[144]  M. Fabbri,et al.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.

[145]  Fengfei Wang,et al.  Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. , 2013, Current medicinal chemistry.

[146]  Keith L Ligon,et al.  Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.

[147]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[148]  R. Buckanovich,et al.  Ovarian cancer stem cells: working towards the root of stemness. , 2013, Cancer letters.

[149]  Shree Ram Singh.  Gastric cancer stem cells: a novel therapeutic target. , 2013, Cancer letters.

[150]  S. Cascinu,et al.  Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients , 2013, PloS one.

[151]  M. Baumann,et al.  Discovery of the cancer stem cell related determinants of radioresistance. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[152]  Andrew E. Sloan,et al.  Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake , 2013, Nature Neuroscience.

[153]  Kanghua Li,et al.  EMT transcription factors: implication in osteosarcoma , 2013, Medical Oncology.

[154]  W. Zimmermann,et al.  CXC Chemokine Receptor 4 is Essential for Maintenance of Renal cell Carcinoma‐Initiating Cells and Predicts Metastasis , 2013, Stem cells.

[155]  Robert A. Weinberg,et al.  Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.

[156]  Tom H. Cheung,et al.  Molecular regulation of stem cell quiescence , 2013, Nature Reviews Molecular Cell Biology.

[157]  H. Hirte,et al.  A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies. , 2013 .

[158]  M. Kahn,et al.  A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors. , 2013 .

[159]  L. Wakefield,et al.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.

[160]  R. Flavell,et al.  Human hemato-lymphoid system mice: current use and future potential for medicine. , 2013, Annual review of immunology.

[161]  J. Balko,et al.  TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. , 2013, The Journal of clinical investigation.

[162]  L. Ailles,et al.  Developmental signaling pathways in cancer stem cells of solid tumors. , 2013, Biochimica et biophysica acta.

[163]  Cord Naujokat,et al.  Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.

[164]  W. de Lau,et al.  Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells , 2012, Stem cells.

[165]  J. Massagué.  TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.

[166]  B. Verdoodt,et al.  Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species , 2012, PloS one.

[167]  V. Valero,et al.  Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer , 2012, Molecular Cancer Therapeutics.

[168]  V. Capra,et al.  Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double‐Strand Break‐Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein , 2012, Brain pathology.

[169]  R. Figlin,et al.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. , 2012, Cancer cell.

[170]  Jiaoti Huang,et al.  The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. , 2012, Cell stem cell.

[171]  F. Bertolini,et al.  Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts , 2012, Laboratory Investigation.

[172]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[173]  M. Wicha,et al.  Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia , 2012, Proceedings of the National Academy of Sciences.

[174]  Jens-Peter Volkmer,et al.  Three differentiation states risk-stratify bladder cancer into distinct subtypes , 2012, Proceedings of the National Academy of Sciences.

[175]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[176]  Richard J. Jones,et al.  Concise Review: Cancer Stem Cells and Minimal Residual Disease , 2012, Stem cells.

[177]  M. Hermanová,et al.  CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines , 2011, Analytical cellular pathology.

[178]  O. Delpuech,et al.  FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression , 2011, Cell Death and Differentiation.

[179]  Yizheng Wang,et al.  The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers , 2011, Cell Research.

[180]  R. Ferris,et al.  Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells , 2011, Clinical Cancer Research.

[181]  Mithat Gönen,et al.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.

[182]  R. Qin,et al.  CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. , 2011, World journal of gastroenterology.

[183]  Li-Yan Xu,et al.  Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44 , 2011, PloS one.

[184]  P. Bragado,et al.  ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease , 2011, Clinical Cancer Research.

[185]  F. Papaccio,et al.  Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  Sophia Hsin-Jung Li,et al.  Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.

[187]  S. Leng,et al.  EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.

[188]  Jørgen Kjems,et al.  Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer , 2011, International journal of cancer.

[189]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[190]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[191]  C. Münz,et al.  Mice with human immune system components as in vivo models for infections with human pathogens , 2011, Immunology and cell biology.

[192]  S. Niclou,et al.  Critical appraisal of the side population assay in stem cell and cancer stem cell research. , 2011, Cell stem cell.

[193]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[194]  Sungpil Yoon,et al.  Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein , 2011, British journal of pharmacology.

[195]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[196]  R. Qin,et al.  CD44+CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma , 2010, Cancer biology & therapy.

[197]  C. Bianco,et al.  Targeting the embryonic gene Cripto-1 in cancer and beyond , 2010, Expert opinion on therapeutic patents.

[198]  Jennifer A. Prescher,et al.  Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models , 2010, Proceedings of the National Academy of Sciences.

[199]  K. Sugamura,et al.  Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines , 2010, Cancer science.

[200]  K. Mimori,et al.  CD13 is a therapeutic target in human liver cancer stem cells. , 2010, The Journal of clinical investigation.

[201]  J. Settleman,et al.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.

[202]  Hailong Wu,et al.  Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype , 2010, Molecular Cancer Therapeutics.

[203]  Eleonora Petrucci,et al.  The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. , 2010, Blood cells, molecules & diseases.

[204]  T. Yau,et al.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.

[205]  B. Vonderhaar,et al.  CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. , 2010, Cancer research.

[206]  N. Agarwal,et al.  CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. , 2010, Cancer research.

[207]  C. Low,et al.  Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. , 2010, Current oncology.

[208]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[209]  K. Kwon,et al.  Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells , 2010, Pancreas.

[210]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[211]  W. Bodmer,et al.  Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.

[212]  M. O’Connor-McCourt,et al.  Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies , 2010, Oncogene.

[213]  G. Tredici,et al.  Biological heterogeneity of putative bladder cancer stem‐like cell populations from human bladder transitional cell carcinoma samples , 2010, Cancer science.

[214]  D. Birnbaum,et al.  CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.

[215]  L. Yang,et al.  Activation of the hedgehog-signaling pathway in human cancer and the clinical implications , 2010, Oncogene.

[216]  J. Rich,et al.  Hypoxia inducible factors in cancer stem cells , 2010, British Journal of Cancer.

[217]  F. Marincola,et al.  Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients , 2010, Clinical Cancer Research.

[218]  R. McLendon,et al.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.

[219]  F. Esposito,et al.  Adaptation to oxidative stress, chemoresistance, and cell survival. , 2009, Antioxidants & redox signaling.

[220]  J. Becker,et al.  Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells. , 2009, Cancer research.

[221]  Howard Y. Chang,et al.  Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells , 2009, Proceedings of the National Academy of Sciences.

[222]  David A Hess,et al.  High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability , 2009, Journal of cellular and molecular medicine.

[223]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[224]  G. Parmigiani,et al.  Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma , 2009, Stem cells.

[225]  Jeffrey M. Rosen,et al.  The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.

[226]  Marcus Fruttiger,et al.  The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis , 2009, Cell.

[227]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[228]  H. Fine,et al.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.

[229]  Zhong Yun,et al.  Hypoxic tumor microenvironment and cancer cell differentiation. , 2009, Current molecular medicine.

[230]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[231]  David García-Dorado,et al.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.

[232]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[233]  C. Jordan.  Cancer stem cells: controversial or just misunderstood? , 2009, Cell stem cell.

[234]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[235]  R. Thompson,et al.  CXCR4 mediates the proliferation of glioblastoma progenitor cells. , 2009, Cancer letters.

[236]  P. Febbo,et al.  Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. , 2009, Cancer cell.

[237]  N. Probst-Hensch,et al.  Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[238]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[239]  M. Todaro,et al.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.

[240]  James Briscoe,et al.  Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network , 2008, Development.

[241]  R. McLendon,et al.  Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.

[242]  P. Carter,et al.  CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers , 2008, British Journal of Cancer.

[243]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[244]  S. Fan,et al.  Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.

[245]  Peter Canoll,et al.  Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.

[246]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[247]  J. Chang,et al.  Bladder Cancer Initiating Cells (BCICs) Are Among EMA−CD44v6+ Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) Cells , 2008, Cancer investigation.

[248]  P. Lichter,et al.  Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients , 2008, Clinical Cancer Research.

[249]  Shelly C. Lu,et al.  Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A–deficient mice , 2007, Hepatology.

[250]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[251]  M. Hollingsworth,et al.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins , 2007, Journal of cellular biochemistry.

[252]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[253]  M. Todaro,et al.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. , 2007, Cell stem cell.

[254]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[255]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[256]  C. Huff,et al.  Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma , 2007, Proceedings of the National Academy of Sciences.

[257]  P. Polakis.  The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[258]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.

[259]  S. Armstrong,et al.  FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.

[260]  P. Sánchez,et al.  HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.

[261]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[262]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[263]  A. Giuliano,et al.  Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.

[264]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[265]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[266]  Amar Gajjar,et al.  Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.

[267]  Tsz-Kwong Man,et al.  Expression profiles of osteosarcoma that can predict response to chemotherapy. , 2005, Cancer research.

[268]  T. Fehm,et al.  A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.

[269]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[270]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[271]  Eric C. Lai,et al.  Notch signaling: control of cell communication and cell fate , 2004, Development.

[272]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[273]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[274]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[275]  P. D’Eustachio,et al.  Essential role of STAT3 for embryonic stem cell pluripotency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[276]  C. Higgins,et al.  The ABC of channel regulation , 1995, Cell.

[277]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[278]  N. Ehlers,et al.  Letter: HL-A27 in acute and chronic uveitis. , 1974, Lancet.

[279]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[280]  M. Arigoni,et al.  Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. , 2016, Cancer research.

[281]  W. Xiaojing,et al.  Sonic hedgehog–Gli1 signals promote epithelial–mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway , 2014, Medical Oncology.

[282]  Cho Y. Lam,et al.  Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[283]  M. Honda,et al.  The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. , 2014, Journal of hepatology.

[284]  M. Herlyn,et al.  Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations. , 2012, Advances in pharmacology.

[285]  M. Reedijk.  Notch signaling and breast cancer. , 2012, Advances in experimental medicine and biology.

[286]  M. Cher,et al.  Circulating tumor cells: finding the needle in the haystack. , 2011, American journal of cancer research.